Higher OLGA and OLGIM stages increase gastric cancer risk.
Higher stages of the OLGA and OLGIM staging systems significantly correlate with an elevated risk of developing high-grade dysplasia (HGD) and gastric cancer (GC). A systematic review and meta-analysis of eight prospective cohort studies found that moving from OLGA/OLGIM categories 0-II to III-IV notably increases the likelihood of these outcomes. This validates the use of these classification systems in evaluating gastric cancer risk and supports their role in developing endoscopic surveillance programs.
An enhanced-recovery pathway after endoscopic removal of small upper gastrointestinal lesions shortened hospital stays without increasing complications.
For cancer-related stomach blockage, endoscopic ultrasound-guided bypass was linked to fewer repeat procedures than stents or surgery, and a shorter hospital stay than surgery.
After EUS-guided drainage for infected necrotizing pancreatitis, immediate necrosectomy showed no clear clinical advantage over waiting to intervene as needed—and may expose more patients to the procedure.
